The Science of Protracted Withdrawal
What Science Can — and Cannot — Tell Us About “Protracted” States
By Coach Powers, Ph.D
Abstract
Long-term symptoms following benzodiazepine discontinuation have been reported for decades, yet the scientific literature continues to face limitations in quantifying prevalence, defining mechanisms, and distinguishing pharmacologic withdrawal from persistent anxiety-related and stress-driven nervous system states. This paper reviews what is known about prolonged symptom reports, the challenges of classification, and why withdrawal-like experiences occurring years later are better explained through models of threat reactivation, interoceptive learning, avoidance reinforcement, trauma response, and expectation effects than through renewed medication injury alone. We also examine why recovery strategies depend on the explanatory model adopted and how reframing symptoms as activation rather than damage provides a more functional path forward.
What We Know — and What We Still Don’t
It is important to approach this topic with responsibility and intellectual honesty.
People do report persistent symptoms after discontinuing benzodiazepines. This has been documented for decades, beginning with early clinical descriptions of prolonged withdrawal syndromes and the difficulty of separating pharmacologic effects from anxiety-related and neurological symptoms that may persist after discontinuation (Ashton, 1991). These reports reflect real suffering and deserve to be taken seriously.
I, myself, Coach Powers, dealt with protracted withdrawal for nearly two years after coming off benzos. Don't ever let anyone tell you, "it's all in your head" or "it's just your pre-existing anxiety reemerging."
More recent literature, however, highlights a key limitation: our ability to precisely quantify the incidence, duration, and mechanisms of long-term post-benzodiazepine symptoms remains limited. Large-scale, controlled studies with robust stratification are scarce, and much of the available data comes from surveys, self-report samples, and qualitative research (Shade et al., 2025).
What these studies consistently show is that a substantial subset of long-term benzodiazepine users report significant difficulty during discontinuation. What they do not establish is that symptoms years later are driven by ongoing pharmacologic injury rather than by persistent nervous system activation, anxiety-related processes, or learned threat responses. This matters.
So the claim here is not that protracted suffering is imaginary. It is real.
The claim is more precise: a withdrawal-like state occurring years later does not automatically indicate renewed withdrawal chemistry.
In many cases, it is more parsimoniously explained by reactivated threat circuitry, learned interoceptive alarm, avoidance reinforcement, and expectation-driven arousal. This model fits what we know about stress physiology, fear learning, and nervous system plasticity, and, importantly, it offers a path forward.
Why the Model Matters for Recovery
How a person explains their symptoms shapes how they respond to them.
When symptoms are interpreted as evidence of permanent or ongoing neurological damage, the natural behavioral response tends to involve increased monitoring, avoidance, retreat, reassurance seeking, constant research, and waiting for time alone to fix the problem. These strategies may reduce fear temporarily, but they also teach the nervous system that danger is real and safety must be externally verified.
Over time, this reinforces hypervigilance.
When symptoms are understood as signs of a learned threat state, the strategy changes. The focus shifts toward reducing reinforcement, rebuilding safety cues, re-engaging gradually with avoided experiences, retraining interpretation, lulling the parasympathetic system, and teaching the nervous system that bodily sensations are not emergencies.
This is not a matter of positive thinking. It is behavioral neuroscience.
When fear remains constantly activated, the nervous system struggles to regulate sleep, mood, digestion, energy, and emotional stability. Healing becomes harder, not because recovery is not happening, but because the system never feels safe enough to settle.
The irony here isn't that our nervous system is broken or doesn't work... it's that it's working too damn well!
It's working in overdrive, all the time.
It's doing precisely what millions of years of evolution have programmed it to do.
Scanning for danger, assessing threat, activating hyperarousal and fight-or-flight states, relocating resources, prioritizing nervous system functions for survival, reactivating mental and emotional memories of trauma, and searching incessantly for a way out of danger.
All the while creating powerful conditioned pathways around all of this.
Learning to relate to fear differently, without resistance or identification, creates the conditions in which neuroplastic recalibration can occur. As the alarm system quiets, the nervous system regains flexibility, confidence, and trust in its ability to move forward.
We then pair this with disengagement of fear stimulus, mental, physical, social, etc.., along with leadership training, and daily rhythm building of parasympathetic somatic retraining.
Why? Because the limbic brain speaks through sensations, not verbage alone. (see Five Senses Limbic Retraining lesson).
The Practical Bottom Line (Without Sugarcoating)
Here is the uncomfortable truth that many people resist, and why it matters.
Sometimes what begins as medication withdrawal evolves into a persistent anxiety pattern. Panic loops, health anxiety, insomnia, avoidance behaviors, and trauma responses can become entrenched, not because someone is broken, but because the nervous system learned to operate in emergency mode and continued running that program.
This does not invalidate the original withdrawal experience. It honors it!
It says, “Of course, your system (Bear) learned this. It was under siege.”
But it also says, “You are not stuck because your brain cannot heal. You are stuck because your nervous system learned threat protection, and learning can be updated.”
That is the most hopeful explanation available, because it is the most actionable and the most aligned with actual neuroscience.
Not the mysterious BIND boogieman that reemerges eight years later to reinjure GABA-A receptors, or kill neurons, etc.
That's just the Bear talking.
Conclusion: The State Is Real. The Story Can Change.
If your symptoms returned after a period of stability, it does not automatically mean your brain has been re-injured. Often, it means your nervous system recognized a familiar pattern: pain, uncertainty, insomnia, fear, hyperarousal, and reactivated an old survival program. It's replaying the 'best of' or 'greatest hits' of your old psych med injury and neurological dysregulation.
It feels like BIND because the state is the same: hyperarousal, vigilance, sensory amplification, catastrophic interpretation, obsessive rumination, terror, panic, and exhaustion.
But the driver is often different: learned threat, stress physiology, reinforcement loops, and expectation effects. I cannot hammer this enough. Your Bear needs to hear this, whether he's ready to adopt a new model of thinking or not. We need not drag him to the table and force him to agree.
We just need to gradually, gently feed him the idea that maybe there really is another explanation here.
The solution, then, is not to spend the next year proving that you are fragile.
It is to teach your nervous system, patiently and repeatedly, that you are safe enough to live again.
That is the work.
And that is why this model matters.
When you're ready, I invite you to have a deeper conversation with me, or to join my Recovery School so you can take a deeper dive into my Four Stage Recovery Program, the Bear Manual, our daily neuroplasticity retraining work, and our various educational and supportive content.
References
Ashton, H. (1991). Protracted withdrawal syndromes from benzodiazepines. Journal of Substance Abuse Treatment, 8(1–2), 19–28.
Shade, K. N., Henningsen, P., & Häuser, W. (2025). Long-term neurological consequences following benzodiazepine discontinuation: A scoping review. Neuroscience & Biobehavioral Reviews, 160, 105–122.